AMB |
Amphotericin B; |
BV |
Bacterial vaginosis; |
CD |
Cyclodextrins; |
CLSM |
Confocal scanning laser microscopy |
CMC |
Carboxymethyl cellulose; |
CP |
Conventional particles; |
EC |
Ethyl cellulose; |
EC |
Ethylcellulose; |
EVA |
Ethylenacetate of vinyl; |
FSAD |
Female sexual arousal disorder; |
HA |
Hyaluronic acid; |
HEC |
Hydroxyethyl cellulose; |
HIV |
Human immunodeficiency virus; |
HLB |
Hydrophilic-lipophilic balance; |
HME |
Hot-melt extrusion; |
HPC |
Hydroxypropyl cellulose; |
HPMC |
Hydroxypropyl methylcellulose; |
HSV |
Herpes simplex virus; |
LIPs |
Liposomes; |
mAB |
Monoclonal antibody; |
MC |
Methylcellulose; |
MCC |
Microcrystalline cellulose; |
MPP |
Mucus penetrating particles; |
Na-CMC |
Sodium carboxymethyl cellulose; |
NC |
Nanocapsules; |
NP |
Nanoparticles; |
NPs |
Polymeric nanoparticles; |
NS |
Nanospheres; |
OPTs |
Osmotic pump tablets; |
PCL |
Polycaprolactone; |
PEG |
Poly(ethylene glycol); |
PEI |
Polyethylenimine; |
PEO |
Poly(ethylene oxide); |
PEO |
Polyethylene oxide; |
PLGA |
Poly(lactic-co-glycolic acid); |
PLGA |
Poly(lactic-co-glycolic) acid; |
PPO |
Poly(propylene oxide); |
PrEP |
Pre-exposure prophylaxis of sexual transmission; |
PVA |
Polyvinyl alcohol; |
PVP |
Polyvinylpyrrolidone; |
QbD |
Quality-by-design; |
RVVC |
Recurrent vulvovaginal candidiasis; |
SC |
Solvent casted; |
siRNA |
Small interfering RNA; |
STD |
Sexually transmitted disease; |
STIs |
Sexuallytransmitted infections; |
VC |
Vaginal candidiasis; |
VFS |
Vaginal fluid stimulant |